Posting of Annual Report and Notice of AGM
23 October 2026
CVS Group plc
(“CVS” or the “Company”)
Posting of Annual Report and Notice of Annual General Meeting
CVS, the UK listed veterinary group and a leading provider of veterinary services, announces that its Annual General Meeting ("AGM") will be held at the offices of Linklaters LLP at 20 Ropemaker Street, London EC2Y 8HQ on 25 November 2026 at 11:00am.
The Annual Report and Accounts for the financial year ended 30 June 2026 (the "Annual Report"), the Notice of AGM and proxy form were sent on 23 October 2026 to those shareholders who have requested hard copies. Shareholders who have elected to receive shareholder information electronically have been notified that the Annual Report and Notice of AGM are available on the Company's website at: https://www.cvsukltd.co.uk/investor-centre, and the forms of proxy are available to shareholders on request by contacting company.secretary@cvsvets.com.
In accordance with UK Listing Rule 6.4.1, copies of the Annual Report and the Notice of AGM have also been uploaded to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The AGM will be held as a physical meeting. The Company encourages shareholders to submit a proxy vote in advance of the AGM. Full details of voting arrangements are contained in the Notice of AGM.
The result of the AGM will be announced shortly after its conclusion and published on the Company’s website.
Stamp Duty Reserve Tax (“SDRT”) and UK Listing Relief
Information regarding the Company's eligibility for UK Listing Relief from SDRT, and guidance for shareholders who wish to seek repayment of SDRT from HMRC in respect of transactions from 29 January 2026 to 24 September 2026 is available in the Investor Centre section of the Company's website (https://www.cvsukltd.co.uk/investor-centre/stamp-duty-reserve-tax-and-uk-listing-relief/).
Contacts:
CVS Group plc via FGS Global
Richard Fairman, CEO
Scott Morrison, Company Secretary
FGS Global (Financial PR)
Faeth Birch cvsgroup@fgsglobal.com
Charlie Chichester +44 (0)207 251 3801
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.
The Group operates over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").
The Group employs 9,000 personnel, including 2,500 veterinary surgeons and 3,300 nurses.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
This content is published by Proactive Investors Limited and made available subject to the terms and conditions of use of its website (see Terms of Use).
Proactive Investors is a full-service financial newswire. We produce independent, objective financial journalism and do not provide personalised investment advice, act as a broker, or recommend specific securities to individual investors.
Financial content published on this Site is produced under the journalist exemption provided for in Article 20 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, and in accordance with FCA guidance at PERG 8.12. Where a communication is not otherwise exempt, it is issued or approved for distribution in the UK by Proactive Investors Limited.
All information used in the preparation of this communication has been compiled from publicly available sources that we believe to be reliable, however, we cannot, and do not, guarantee the accuracy or completeness of this communication.
This communication is intended for information purposes only and does not constitute investment advice, a personal recommendation, an offer, solicitation, or inducement to buy or sell any investment or financial product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
This communication has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Before entering into any transaction, investors should consider suitability for their individual circumstances and should read the relevant prospectus, term sheet, subscription agreement, information memorandum, prospectus or other offering document in full.
Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise, and you may not recover the amount you invest.
This communication may contain information obtained from third parties, including credit ratings and financial data. Reproduction and distribution of third-party content in any form is prohibited except with the prior written consent of the relevant third party. Credit ratings are statements of opinion and should not be relied upon as investment advice.
FOR OUR FULL DISCLAIMER CLICK HERE